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2016 Hospital Profile
Overview / Size Payer Mix
Hospital System Affiliation: Public Payer Mix:
Change in Ownership (FY12-16): CY15 Commercial S-RP:
Total Staffed Beds: Top 3 Commercial Payers:
% Occupancy:
Special Public Funding:
Change FY15-FY16:
Financial Emergency Department Visits in FY16:
Inpatient NPSR per CMAD: Change FY15-FY16:
Outpatient Visits in FY16:
For descriptions of the metrics, please see the technical appendix.
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Not Applicable 1.50
30
90.3%
1,270
Aetna HealthNot Applicable
Trauma Center Designation: Not Applicable
Case Mix Index:
45.9% (Non-HPP* Hospital)
Blue Cross Blue Shield of MA
Harvard Pilgrim Health Care
Not Applicable
1.0%
Utilization
2.13, > cohort avg. (2.03); > statewide (1.07)
Inpatient Discharges in FY16:
Inpatient:Outpatient Revenue in FY16: 4%:96% Change FY15-FY16: 3.8%
$13,888
Change FY15-FY16: -13.1% 269,325
DANA-FARBER CANCER INSTITUTE
Boston, MA
Specialty Hospital
Metro Boston
Dana-Farber Cancer Institute is a non-profit specialty hospital dedicated to pediatric and adult cancer treatment and research, located in the Metro Boston 
region. It is a teaching affiliate of Harvard Medical School. It is one of 48 Comprehensive Cancer Centers in the US, designated by the National Cancer 
Institute. Dana-Farber Cancer Institute provides the majority of its care in an outpatient setting and had 1,270 inpatient discharges compared to 269,325 
outpatient visits in FY16. 
Change FY11-FY15 (percentage points):
Outpatient Revenue in FY16: $782,389,421
Quality
Early Elective Deliveries Rate (Jan 2015-Jun 2016): Not Applicable
Not Applicable
What proportion of adult patient discharges from this hospital resulted 
in a readmission at any hospital within 30 days, and how does this 
compare to the state average?
How many central line-associated blood stream infections (CLABSI), 
catheter-associated urinary tract infections (CAUTI), and surgical site 
infections (SSI) after colon surgery did patients get at this hospital 
compared to what was expected based on the hospital's characteristics 
and case mix?
Total Revenue in FY16: $1,381,541,054
 
Total Surplus (Loss) in FY16: $43,326,978
Change FY15-FY16: 18.1%
Readmission Rate in FY15:
What were the most common inpatient cases (DRGs) treated at the 
hospital in FY16? What proportion of the region’s cases did this 
hospital treat for each service? 
Where did most of the hospital's inpatients reside? What proportion of 
each community's total discharges was attributed to this hospital?
 - - - Hospital  (1,270) = 0%  of total regional  discharges 
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Data is not available for these measures. This measure is not applicable to the patient 
 population treated at this specialty hospital. 
This graph has been suppressed, as no community 
accounted for more than 2% of the hospital's total 
discharges. 
This graph has been suppressed, as the hospital provides the vast 
majority of its services on an outpatient basis. In FY16, this hospital 
reported 143,069 infusion treatments and over 269,000 outpatient visits. 
A59
Key:
Hospital
Cohort: Specialty Hospital Peer Cohort
For descriptions of the metrics, please see the technical appendix.
* High Public Payer Hospitals (HPP) receive a minimum of 63% of gross patient service revenue from public payers.
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How has the volume of the hospital's inpatient discharges changed 
compared to FY12, and how does this compare to the hospital's peer 
cohort median? (FY12=100)
How has the volume of the hospital's outpatient visits changed 
compared to FY12, and how does this compare to the hospital's peer 
cohort median? (FY12=100)
What was the hospital's net inpatient service revenue per case mix 
adjusted discharge between FY12 and FY16, and how does this 
compare to the hospital's peer cohort median?
How has the hospital's total outpatient revenue changed compared to 
FY12, and how does this compare to the hospital's peer cohort 
median? (FY12=100)
How have the hospital's total revenue and costs changed between 
FY12 and FY16?
What were the hospital's total margin and operating margins between 
FY12 and FY16, and how do these compare to the hospital's peer 
cohort medians?
Revenue, Cost, & Profit/Loss (in millions)
FY 2012 2013 2014 2015
88$        
 Operating Revenue 938$      975$      1,019$   1,117$   1,293$   
Non-Operating 
Revenue
71$        104$      79$        53$        
1,338$   
Total Revenue 1,008$   1,078$   1,098$   1,171$   1,382$   
Total Costs 985$      1,022$   1,064$   1,166$   
Total Profit (Loss) 23.4$     56.2$     34.6$     4.7$       43.3$     
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FY16 Outpatient Visits = 269,325 
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FY16 Outpatient Revenue = $782 M 
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